precisionmedicineleaderssummit.com
EXHIBITORS - Precision Medicine Leaders Summit
http://www.precisionmedicineleaderssummit.com/exhibitors
PRECISION MEDICINE LEADERS SUMMIT. AUGUST 21-24 2017 / HILTON SAN DIEGO BAYFRONT. Redwood Shores, CA 94065. San Francisco, CA 94111. Sponsorship / Exhibit Prospectus. Event Terms and Conditions. For Speaking, Sponsorship, and Exhibiting opportunities:. For Registration and Hotel inquiries:.
news.n-of-one.com
N-of-One: Customized Cancer Treatment Strategies™ News: EGFR Emerges as a Target for Cervical Cancer Therapy
http://news.n-of-one.com/2011/08/egfr-emerges-as-target-for-cervical.html
Science and Medical Advisors. Non-small Cell Lung Cancer. Non-Small Cell Lung Cancer. Understanding Side Effects of Targeted Therapies t. Toward Predisposition Genes for Esophageal Adenoca. News from the Lung Cancer Mutation Consortium. A Greater Understanding of Triple-Negative Breast . Personalized Medicine Trial a Good Early Start. Melanoma Drug Results Impress at ASCO. Steps Toward Establishing PARP As a Biomarker to G. Study Recommends Expanded Screening of Lung Cancer. Monday, August 22, 2011.
news.n-of-one.com
N-of-One: Customized Cancer Treatment Strategies™ News: Kris Carr: "The Leap from 'Cancer Person' to 'Total Wellness' Guru"
http://news.n-of-one.com/2011/08/kris-carr-leap-from-cancer-person-to.html
Science and Medical Advisors. Non-small Cell Lung Cancer. Non-Small Cell Lung Cancer. EGFR Emerges as a Target for Cervical Cancer Thera. Understanding Side Effects of Targeted Therapies t. Toward Predisposition Genes for Esophageal Adenoca. News from the Lung Cancer Mutation Consortium. A Greater Understanding of Triple-Negative Breast . Personalized Medicine Trial a Good Early Start. Melanoma Drug Results Impress at ASCO. Steps Toward Establishing PARP As a Biomarker to G. Monday, August 22, 2011.
news.n-of-one.com
N-of-One: Customized Cancer Treatment Strategies™ News: A Call for Personalized Therapies for Bladder Cancer
http://news.n-of-one.com/2011/09/call-for-personalized-therapies-for.html
Science and Medical Advisors. Non-small Cell Lung Cancer. Non-Small Cell Lung Cancer. Phase I Trial Signals Promise for Virus-Based Ther. Kris Carr: The Leap from Cancer Person to Tota. EGFR Emerges as a Target for Cervical Cancer Thera. Understanding Side Effects of Targeted Therapies t. Toward Predisposition Genes for Esophageal Adenoca. News from the Lung Cancer Mutation Consortium. A Greater Understanding of Triple-Negative Breast . Personalized Medicine Trial a Good Early Start. For instance, the au...
news.n-of-one.com
N-of-One: Customized Cancer Treatment Strategies™ News: Two Studies Support Use of Avastin in Advanced Ovarian Cancer
http://news.n-of-one.com/2012/01/two-studies-support-use-of-avastin-in.html
Science and Medical Advisors. Non-small Cell Lung Cancer. Non-Small Cell Lung Cancer. Cetuximab Benefits a Subset of NSCLC Patients. Differentiating Between BRCA1 and BRCA2 Mutations . A Call for Personalized Therapies for Bladder Canc. Phase I Trial Signals Promise for Virus-Based Ther. Kris Carr: The Leap from Cancer Person to Tota. EGFR Emerges as a Target for Cervical Cancer Thera. Understanding Side Effects of Targeted Therapies t. Toward Predisposition Genes for Esophageal Adenoca.
experts.n-of-one.com
N-of-One Experts' Column: April 2012
http://experts.n-of-one.com/2012_04_01_archive.html
N-of-One - Powering Precision Medicine. What is Precision Medicine? Science and Medical Advisors. Drug and Technology Innovators. About Molecular Targeted Therapy. Is My Cancer Different? Looking for a Clinical Trial? What's New in Molecular Targeted Therapy? About Molecular Targeted Therapy. Is My Cancer Different? Looking for a Clinical Trial? Tuesday, April 10, 2012. A Recent Study Supports Targeted therapy to Reduce the Risk of Recurrence in GIST. Tuesday, April 3, 2012. The recent data published in...
experts.n-of-one.com
N-of-One Experts' Column: A Recent Study Supports Targeted therapy to Reduce the Risk of Recurrence in GIST
http://experts.n-of-one.com/2012/04/recent-study-supports-targeted-therapy.html
N-of-One - Powering Precision Medicine. What is Precision Medicine? Science and Medical Advisors. Drug and Technology Innovators. About Molecular Targeted Therapy. Is My Cancer Different? Looking for a Clinical Trial? What's New in Molecular Targeted Therapy? About Molecular Targeted Therapy. Is My Cancer Different? Looking for a Clinical Trial? Tuesday, April 10, 2012. A Recent Study Supports Targeted therapy to Reduce the Risk of Recurrence in GIST. Brand Design and Website by MicroArts Creative Agency.
SOCIAL ENGAGEMENT